Education

             Tyler I. Sainkoudje is a Doctor in Pharmacy (Pharm.D.) with a Master of Pharmaceutical Science (M.S.) of Discovery, Development & Quality Control of New Medicinal Products.

2009 – 2010: Doctor in Pharmacy diploma

European University of Brittany – Rennes, France

Disserted (with honor) June 1st 2010 on: The analysis of the American New Drug Application type 505(b)(2) for innovative generic drugs registration and comparison with the similar applications in Europe and France

​2005: Project Management certificate

Project Management Institute – Montreal, Canada​

1998 – 1999: Master of Industrial Pharmacy on drug conception, manufacturing and analysis - European University of Brittany – Rennes, France

​

1992 – 1998: Complete PharmD program

European University of Brittany – Rennes, France

Validated optional certificates:

- Foodstuffs Safety and Environment - 1998​

- Drug Pharmaceutical Design and Business - 1997

- Deepened Chemical Analysis in 1995

- Methodology in Cellular Biology - 1995

- Endocrinal Biochemistry - 1994

​1991 – 1992: Technical Degree in Applied Biology

Technical Institute of Clermont-Ferrand, France

Academic Publications 

2010: Analyse de la procédure 505(b)(2) de la réglementation américaine relative aux demandes d'autorisation de mise sur le marché de médicaments génériques innovants et comparaison avec les procédures similaires en Europe et en France

​

1999: AstraZeneca - Unité de production de Reims

​

1999: Epidemiological study - Statistical modeling & analysis in SPSS of Adverse effects of existing drugs in Alzheimer's disease.

​

1992: SmithKline & Beecham - Preclinical study &  In Vitro pharmacological screening of new chemical entities in the congestive heart failure.